NAVB logo

NAVB Accounts Receivable

Annual Accounts Receivable

$600.00
-$400.00-40.00%

December 31, 2022


Summary


Performance

NAVB Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAVBbalance sheetmetrics:

Quarterly Accounts Receivable

$30.90 K
-$13.80 K-30.87%

September 30, 2023


Summary


Performance

NAVB Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAVBbalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

NAVB Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-40.0%-30.9%
3 y3 years+100.0%-30.9%
5 y5 years+100.0%-30.9%

NAVB Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-40.0%at low-80.1%+5050.0%
5 y5-year-99.0%-100.0%-98.2%-100.0%
alltimeall time-100.0%-100.0%-99.8%-100.0%

Navidea Biopharmaceuticals Accounts Receivable History

DateAnnualQuarterly
Sep 2023
-
$30.90 K(-30.9%)
Jun 2023
-
$44.70 K(+44.2%)
Mar 2023
-
$31.00 K(+5066.7%)
Dec 2022
$600.00(-40.0%)
$600.00(-99.6%)
Sep 2022
-
$155.20 K(+415.6%)
Jun 2022
-
$30.10 K(-74.0%)
Mar 2022
-
$115.80 K(>+9900.0%)
Dec 2021
$1000.00(-98.3%)
$1000.00(-98.3%)
Dec 2020
$58.80 K(>+9900.0%)
$58.80 K(-96.5%)
Mar 2020
-
$1.70 M(>+9900.0%)
Dec 2019
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2019
-
$145.80 K(-29.5%)
Jun 2019
-
$206.90 K(+1989.9%)
Mar 2019
-
$9900.00(-20.2%)
Dec 2018
$12.40 K(>+9900.0%)
$12.40 K(-85.7%)
Sep 2018
-
$86.90 K(-76.8%)
Jun 2018
-
$373.90 K(-97.1%)
Mar 2018
-
$12.96 M(>+9900.0%)
Dec 2017
$0.00(-100.0%)
$0.00(-100.0%)
Dec 2016
$18.40 K(-99.3%)
$18.40 K(-99.3%)
Dec 2015
$2.50 M(+206.0%)
$2.50 M(+30.8%)
Sep 2015
-
$1.91 M(+4.4%)
Jun 2015
-
$1.83 M(+51.1%)
Mar 2015
-
$1.21 M(+48.3%)
Dec 2014
$816.50 K(-29.0%)
$816.50 K(-44.3%)
Sep 2014
-
$1.47 M(+200.8%)
Jun 2014
-
$487.10 K(-17.0%)
Mar 2014
-
$586.70 K(-49.0%)
Dec 2013
$1.15 M(+6437.5%)
$1.15 M(+629.2%)
Sep 2013
-
$157.80 K(+82.9%)
Jun 2013
-
$86.30 K(+393.1%)
Mar 2013
-
$17.50 K(-0.6%)
Dec 2012
$17.60 K(+11.4%)
$17.60 K(-22.8%)
Sep 2012
-
$22.80 K(+159.1%)
Jun 2012
-
$8800.00(-65.9%)
Mar 2012
-
$25.80 K(+63.3%)
Dec 2011
$15.80 K(-99.2%)
$15.80 K(-91.2%)
Sep 2011
-
$179.90 K(-91.2%)
Jun 2011
-
$2.03 M(+11.4%)
Mar 2011
-
$1.82 M(-10.9%)
Dec 2010
$2.05 M
$2.05 M(+48.2%)
DateAnnualQuarterly
Sep 2010
-
$1.38 M(-27.1%)
Jun 2010
-
$1.90 M(+67.0%)
Mar 2010
-
$1.14 M(-14.7%)
Dec 2009
$1.33 M(-18.1%)
$1.33 M(-4.4%)
Sep 2009
-
$1.39 M(+21.5%)
Jun 2009
-
$1.15 M(-32.0%)
Mar 2009
-
$1.69 M(+3.6%)
Dec 2008
$1.63 M(+0.3%)
$1.63 M(+23.6%)
Sep 2008
-
$1.32 M(+16.4%)
Jun 2008
-
$1.13 M(-6.8%)
Mar 2008
-
$1.21 M(-25.2%)
Dec 2007
$1.62 M(+30.2%)
$1.62 M(+16.9%)
Sep 2007
-
$1.39 M(+21.4%)
Jun 2007
-
$1.14 M(+16.9%)
Mar 2007
-
$977.90 K(-21.5%)
Dec 2006
$1.25 M(+85.2%)
$1.25 M(+88.0%)
Sep 2006
-
$662.80 K(-27.3%)
Jun 2006
-
$911.20 K(+28.2%)
Mar 2006
-
$710.80 K(+5.6%)
Dec 2005
$673.00 K(+63.4%)
$673.00 K(-23.1%)
Sep 2005
-
$874.60 K(+135.7%)
Jun 2005
-
$371.00 K(-59.3%)
Mar 2005
-
$912.10 K(+121.4%)
Dec 2004
$411.90 K(-62.8%)
$411.90 K(-44.8%)
Sep 2004
-
$746.40 K(+30.6%)
Jun 2004
-
$571.30 K(-30.5%)
Mar 2004
-
$821.70 K(-25.8%)
Dec 2003
$1.11 M(+48.5%)
$1.11 M(-2.3%)
Sep 2003
-
$1.13 M(-24.7%)
Jun 2003
-
$1.51 M(+64.3%)
Mar 2003
-
$916.50 K(+22.8%)
Dec 2002
$746.10 K(+33.0%)
$746.10 K(+77.5%)
Sep 2002
-
$420.40 K(-10.2%)
Jun 2002
-
$468.10 K(+151.7%)
Mar 2002
-
$186.00 K(-66.9%)
Dec 2001
$561.10 K(+53.7%)
$561.10 K(+1088.8%)
Sep 2001
-
$47.20 K(-65.4%)
Jun 2001
-
$136.30 K(-72.1%)
Mar 2001
-
$488.60 K(+33.8%)
Dec 2000
$365.10 K(-82.4%)
$365.10 K(-82.4%)
Dec 1998
$2.07 M(+160.9%)
$2.07 M(+160.9%)
Dec 1997
$793.40 K
$793.40 K

FAQ

  • What is Navidea Biopharmaceuticals annual accounts receivable?
  • What is the all time high annual accounts receivable for Navidea Biopharmaceuticals?
  • What is Navidea Biopharmaceuticals annual accounts receivable year-on-year change?
  • What is Navidea Biopharmaceuticals quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Navidea Biopharmaceuticals?
  • What is Navidea Biopharmaceuticals quarterly accounts receivable year-on-year change?

What is Navidea Biopharmaceuticals annual accounts receivable?

The current annual accounts receivable of NAVB is $600.00

What is the all time high annual accounts receivable for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high annual accounts receivable is $2.50 M

What is Navidea Biopharmaceuticals annual accounts receivable year-on-year change?

Over the past year, NAVB annual accounts receivable has changed by -$400.00 (-40.00%)

What is Navidea Biopharmaceuticals quarterly accounts receivable?

The current quarterly accounts receivable of NAVB is $30.90 K

What is the all time high quarterly accounts receivable for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high quarterly accounts receivable is $12.96 M

What is Navidea Biopharmaceuticals quarterly accounts receivable year-on-year change?

Over the past year, NAVB quarterly accounts receivable has changed by -$13.80 K (-30.87%)